Pfizer inks collaboration deal to use CytoReason’s cell-centered models of immune system:
Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason (Hebrew)
From Mouse to man: New Machine Learning Model Reduces Number of ‘Wasted Experiments’
Five AI Healthcare Startups Bringing Us Closer to Cures
Interview with Systems Immunology Expert Prof. Shai Shen-Orr
9 AI-based initiatives catalyzing immunotherapy in 2018
AI in Drug Development Podcast – Anchor FM
CytoReason’s Machine-Learning Model Offers New Insights Into Immune-Related Diseases
CytoReason uses AI to personalize drugs, opening the door to cancer treatments
Hey Doc, how’s my immune system doing? Shen-Orr
